Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.31B |
| 2 |
GSK
GSK
|
+$624M |
| 3 |
Meta Platforms (Facebook)
META
|
+$609M |
| 4 |
UnitedHealth
UNH
|
+$335M |
| 5 |
Microsoft
MSFT
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$611M |
| 2 |
Toronto Dominion Bank
TD
|
+$216M |
| 3 |
GE Aerospace
GE
|
+$195M |
| 4 |
CF Industries
CF
|
+$193M |
| 5 |
Mondelez International
MDLZ
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.58% |
| 2 | Energy | 8.65% |
| 3 | Industrials | 8.54% |
| 4 | Technology | 7.61% |
| 5 | Communication Services | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
501
CALL
Microsoft
MSFT
$3.72T
| $63M | 0.03% |
737,000
-546,100
| -43% | -$44.8M |
|
502
Constellation Brands
STZ
$22.7B
| $62.9M | 0.03% |
275,296
+7,933
| +3% | +$1.71M |
|
503
Ford
F
$55.7B
| $62.7M | 0.03% |
5,019,512
+427,836
| +9% | +$5.27M |
|
|
CPE
504
DELISTED
Callon Petroleum Company
CPE
| $62.7M | 0.03% |
515,857
+8,658
| +2% | +$959K |
|
505
KLA
KLAC
$271B
| $62.5M | 0.03% |
5,949,460
+4,328,550
| +267% | +$45.6M |
|
506
Kinross Gold
KGC
$33.1B
| $62.5M | 0.03% |
14,465,721
+988,800
| +7% | +$4.12M |
|
507
PUT
Biogen
BIIB
$29.7B
| $62.4M | 0.03% |
195,900
| – | – |
|
508
Johnson Controls International
JCI
$94.7B
| $62.4M | 0.03% |
1,636,909
-2,622,931
| -62% | -$102M |
|
509
Tyler Technologies
TYL
$13B
| $62.3M | 0.03% |
352,143
-87,255
| -20% | -$15.5M |
|
510
iShares S&P 500 Growth ETF
IVW
$77.6B
| $62.1M | 0.03% |
1,626,252
+81,540
| +5% | +$3.05M |
|
511
PUT
SLB Ltd
SLB
$78.9B
| $62M | 0.03% |
920,600
+392,400
| +74% | +$25.4M |
|
|
NVO
512
Novo Nordisk
NVO
$200B
| $61.8M | 0.03% |
2,303,286
+155,386
| +7% | +$3.95M |
|
513
Vanguard Morningstar Large-Cap ETF
VV
$54.5B
| $61.6M | 0.03% |
502,619
+10,598
| +2% | +$1.27M |
|
514
InterDigital
IDCC
$8.73B
| $61.5M | 0.03% |
808,045
-27,831
| -3% | -$2.08M |
|
515
Universal Electronics
UEIC
$74.6M
| $61.5M | 0.03% |
1,301,111
-90,061
| -6% | -$4.99M |
|
516
Tyson Foods
TSN
$19.7B
| $61.4M | 0.03% |
757,453
+301,684
| +66% | +$23.1M |
|
517
AerCap
AER
$23.6B
| $61.3M | 0.03% |
1,164,726
-174,156
| -13% | -$9.07M |
|
518
Agilent Technologies
A
$42B
| $61.3M | 0.03% |
914,595
+457,706
| +100% | +$30.9M |
|
519
Archer Daniels Midland
ADM
$38.6B
| $61.2M | 0.03% |
1,527,604
-433,212
| -22% | -$17.8M |
|
520
iShares Russell Mid-Cap Growth ETF
IWP
$21B
| $61.2M | 0.03% |
1,014,672
+52,050
| +5% | +$3.06M |
|
521
Bausch Health
BHC
$2.3B
| $61M | 0.03% |
2,933,622
+989,620
| +51% | +$15.7M |
|
522
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.87B
| $60.8M | 0.03% |
1,908,638
+199,154
| +12% | +$6.47M |
|
523
PUT
Starbucks
SBUX
$121B
| $60.4M | 0.03% |
1,051,200
+293,200
| +39% | +$16.6M |
|
524
McKesson
MCK
$104B
| $60.2M | 0.03% |
386,218
-116,262
| -23% | -$17.2M |
|
525
Carnival Corporation Ltd
CCL
$38B
| $60M | 0.03% |
904,633
-309,888
| -26% | -$20.5M |
|
Similar funds
Royal Bank of Canada's Q4 2017 Portfolio in Review
As of Q4 2017, Royal Bank of Canada held 7,447 positions worth $228B, up 9.4% from $208B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada deployed $9.66B of net new capital in Q4 2017, opening 331 new positions and adding to 2,461 existing holdings. Its largest new stake was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Energy and Industrials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $611M trimmed.
- Royal Bank of Canada's largest Q4 2017 buy was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.
- Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $2.31B increase.
- Royal Bank of Canada's biggest Q4 2017 reduction was iShares Core S&P 500 ETF, cutting an estimated $611M.
- Royal Bank of Canada fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $144M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $228B portfolio in Q4 2017.
- Royal Bank of Canada opened 331 new positions and closed 486 in Q4 2017.
- Royal Bank of Canada's portfolio value rose 9.4% quarter-over-quarter to $228B.
Based on Royal Bank of Canada's 13F filing for Q4 2017, filed 14 Feb 2018.